Comorbidities of chronic rhinosinusitis in children and adults.

allergy asthma chronic rhinosinusitis non‐steroidal anti‐inflammatory drug exacerbated respiratory disease rhinitis

Journal

Clinical and translational allergy
ISSN: 2045-7022
Titre abrégé: Clin Transl Allergy
Pays: England
ID NLM: 101576043

Informations de publication

Date de publication:
Apr 2024
Historique:
revised: 22 02 2024
received: 12 12 2023
accepted: 02 04 2024
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 24 4 2024
Statut: ppublish

Résumé

Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the nose and paranasal sinuses lasting ≥12 weeks. CRS may exist with (CRSwNP) or without (CRSsNP) nasal polyps. The aim was to evaluate conditions associated with CRS in a randomized hospital cohort. We hypothesized that comorbidities and surgical procedures differ between pediatric and adult patients. This study consisted of hospital registry data of a random sample of rhinosinusitis patients (age range 0-89 years) with the diagnosis of J32 or J33, correspondingly, registered during outpatient visits from 2005 to 2019 (n = 1461). The covariates of interest were collected from electronic health records based on ICD-10 codes and keyword searches. Among pediatric patients (n = 104), the relative proportions of CRSsNP and CRSwNP were 86% and 14% respectively. The relative proportions of adult patients (n = 1357) with CRSsNP and CRSwNP were 60% and 40%, respectively. The following comorbidities significantly differed (p < 0.05) between pediatric and adult populations: allergy, chronic otitis media, and tonsillar diseases. In total, 41 % of the children and 46% of the adults underwent baseline endoscopic sinus surgery (ESS). Additional surgeries of the ear, nose and pharynx were significantly more common among children compared with adults. Risk of revision after baseline ESS was associated (p < 0.05) with allergy, asthma, eosinophilia, CRSwNP, immunodeficiency or its suspicion, non-steroidal anti-inflammatory drug exacerbated respiratory disease, and number of any diseases ≥2. Our study showed that comorbidities differ between pediatric and adult rhinosinusitis patients, as allergy, asthma and allergy, chronic otitis media, mental health disorders, and tonsils disease were significantly more prevalent among pediatric patients. Children and adults were equally treated with ESS. Notably, children underwent additional surgery on adenoids and tonsils more frequently. The effectiveness of ESS in multimorbid adults should be assessed at an individual level.

Sections du résumé

BACKGROUND BACKGROUND
Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the nose and paranasal sinuses lasting ≥12 weeks. CRS may exist with (CRSwNP) or without (CRSsNP) nasal polyps. The aim was to evaluate conditions associated with CRS in a randomized hospital cohort. We hypothesized that comorbidities and surgical procedures differ between pediatric and adult patients.
METHODS METHODS
This study consisted of hospital registry data of a random sample of rhinosinusitis patients (age range 0-89 years) with the diagnosis of J32 or J33, correspondingly, registered during outpatient visits from 2005 to 2019 (n = 1461). The covariates of interest were collected from electronic health records based on ICD-10 codes and keyword searches.
RESULTS RESULTS
Among pediatric patients (n = 104), the relative proportions of CRSsNP and CRSwNP were 86% and 14% respectively. The relative proportions of adult patients (n = 1357) with CRSsNP and CRSwNP were 60% and 40%, respectively. The following comorbidities significantly differed (p < 0.05) between pediatric and adult populations: allergy, chronic otitis media, and tonsillar diseases. In total, 41 % of the children and 46% of the adults underwent baseline endoscopic sinus surgery (ESS). Additional surgeries of the ear, nose and pharynx were significantly more common among children compared with adults. Risk of revision after baseline ESS was associated (p < 0.05) with allergy, asthma, eosinophilia, CRSwNP, immunodeficiency or its suspicion, non-steroidal anti-inflammatory drug exacerbated respiratory disease, and number of any diseases ≥2.
CONCLUSIONS CONCLUSIONS
Our study showed that comorbidities differ between pediatric and adult rhinosinusitis patients, as allergy, asthma and allergy, chronic otitis media, mental health disorders, and tonsils disease were significantly more prevalent among pediatric patients. Children and adults were equally treated with ESS. Notably, children underwent additional surgery on adenoids and tonsils more frequently. The effectiveness of ESS in multimorbid adults should be assessed at an individual level.

Identifiants

pubmed: 38658181
doi: 10.1002/clt2.12354
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12354

Subventions

Organisme : State funding for university-level health research
ID : TYH2019322
Organisme : The Väinö and Laina Kivi Foundation
Organisme : Finnish Society of Allergology and Immunology
Organisme : The Jane and Aatos Erkko Foundation
Organisme : The Tampere Tuberculosis Foundation
Organisme : The Paulo Foundation
Organisme : Allergy Research Foundation
Organisme : The Finnish ORL-HNS Foundation
Organisme : The Jalmari and Rauha Ahokas Foundation

Informations de copyright

© 2024 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.

Références

Fokkens WJ, Hopkins C, Hellings PW, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1‐464. https://doi.org/10.4193/Rhin20.600
Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe ‐ an underestimated disease. A GA(2)LEN study. Allergy. 2011;66(9):1216‐1223. https://doi.org/10.1111/j.1398‐9995.2011.02646.x
Lai L, Hopp RJ, Lusk RP. Pediatric chronic sinusitis and asthma: a review. J Asthma. 2006;43(10):719‐725. https://doi.org/10.1080/02770900600620269
Christensen DN, Franks ZG, McCrary HC, Saleh AA, Chang EH. A systematic review of the association between cigarette smoke exposure and chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2018;158(5):801‐816. https://doi.org/10.1177/0194599818757697
Laulajainen‐Hongisto A, Lyly A, Hanif T, et al. Genomics of asthma, allergy and chronic rhinosinusitis: novel concepts and relevance in airway mucosa. Clin Transl Allergy. 2020;10(1):45. n/a. https://doi.org/10.1186/s13601‐020‐00347‐6
Zhang J, Li Y, Lu X, et al. Distinguishing the dominant species of pathogen in maxillary sinusitis by sequencing DNA dataset analysis. Gene. 2015;561(2):256‐260. https://doi.org/10.1016/j.gene.2015.02.037
Mady LJ, Schwarzbach HL, Moore JA, Boudreau RM, Willson TJ, Lee SE. Air pollutants may be environmental risk factors in chronic rhinosinusitis disease progression. Int Forum Allergy Rhinol. 2018;8(3):377‐384. https://doi.org/10.1002/alr.22052
Berger G, Kogan T, Paker M, Berger‐Achituv S, Ebner Y. Pediatric chronic rhinosinusitis histopathology. Otolaryngol Head Neck Surg. 2011;144(1):85‐90. https://doi.org/10.1177/0194599810390443
Soler ZM, Sauer DA, Mace J, Smith TL. Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2009;141(4):454‐461. https://doi.org/10.1016/j.otohns.2009.06.085
Poachanukoon O, Nanthapisal S, Chaumrattanakul U. Pediatric acute and chronic rhinosinusitis: comparison of clinical characteristics and outcome of treatment. Asian Pac J Allergy Immunol. 2012;30(2):146‐151.
Soler ZM, Mace J, Smith TL. Symptom‐based presentation of chronic rhinosinusitis and symptom‐specific outcomes after endoscopic sinus surgery. Am J Rhinol. 2008;22(3):297‐301. https://doi.org/10.2500/ajr.2008.22.3172
Chang CC, Tai CJ, Ng TY, Tsou YA, Tsai MH. Can FESS combined with submucosal resection (SMR)/septoplasty reduce revision rate? Otolaryngol Head Neck Surg. 2014;151(4):700‐705. https://doi.org/10.1177/0194599814543778
Mascarenhas JG, da Fonseca VMG, Chen VG, et al. Long‐term outcomes of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyps. Braz J Otorhinolaryngol. 2013;79(3):306‐311. https://doi.org/10.5935/1808‐8694.20130055
Nuutinen M, Lyly A, Virkkula P, et al. The relative proportion of comorbidities among rhinitis and rhinosinusitis patients and their impact on visit burden. Clin Transl Allergy. 2022;12(7):e12181‐n/a. https://doi.org/10.1002/clt2.12181
NOMESCO Classification of Surgical Procedures (NCSP), Version 1.16:2011.; 2011. https://nhwstat.org
Fokkens W, Lund BC, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2005;18(18):1‐87. https://doi.org/10.4193/rhin20.600
Fokkens WJ, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology. 2007;45(20):1‐136.
Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology. 2012;50(23):4‐305.
Bayer K, Hamidovic S, Besser G, Mueller CA, Liu DT. Factors associated with revision sinus surgery in patients with chronic rhinosinusitis. J Personalized Med. 2022;12(2):167. https://doi.org/10.3390/jpm12020167
Lilja MJ, Koskinen A, Virkkula P, et al. Factors affecting the control of chronic rhinosinusitis with nasal polyps: a comparison in patients with or without NERD. Allergy Rhinol. 2021;12:215265672110038. https://doi.org/10.1177/21526567211003844
R Core Team. R: A Language and Environment for Statistical Computing; 2020. Published online.
Terry T. A Package for Survival Analysis in R; 2023. Published online.
Hadley W, Romain F, Lionel H, Kirill M, Davis V. dplyr: A Grammar of Data Manipulation; 2023. Published online.
Eddelbuettel D, François R. Rcpp: seamless R and C++ integration. J Stat Software. 2011;40(8):1‐18. https://doi.org/10.18637/jss.v040.i08
Sedaghat AR, Phipatanakul W, Cunningham MJ. Prevalence of and associations with allergic rhinitis in children with chronic rhinosinusitis. Int J Pediatr Otorhinolaryngol. 2013;78(2):343‐347. https://doi.org/10.1016/j.ijporl.2013.12.006
Tantimongkolsuk C, Pornrattanarungsee S, Chiewvit P, Visitsunthorn N, Ungkanont K, Vichyanond P. Pediatric sinusitis: symptom profiles with associated atopic conditions. J Med Assoc Thail. 2005;88(8):S149‐S155.
Anamika A, Chakravarti A, Kumar R. Atopy and quality of life in pediatric chronic rhinosinusitis. Am J Rhinol Allergy. 2019;33(5):586‐590. https://doi.org/10.1177/1945892419854266
Slavin RG. The upper and lower airways: the epidemiological and pathophysiological connection. Allergy Asthma Proc. 2008;29(6):553‐556. https://doi.org/10.2500/aap.2008.29.3169
Ryu G, Min C, Park B, Choi HG, Mo JH. Bidirectional association between asthma and chronic rhinosinusitis: two longitudinal follow‐up studies using a national sample cohort. Sci Rep. 2020;10(1):9589. https://doi.org/10.1038/s41598‐020‐66479‐8
Patterson CC, Harjutsalo V, Rosenbauer J, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study. Diabetologia. 2019;62(3):408‐417. https://doi.org/10.1007/s00125‐018‐4763‐3
Muller LMAJ, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41(3):281‐288. https://doi.org/10.1086/431587
Abu‐Ashour W, Twells LK, Valcour JE, Gamble JM. Diabetes and the occurrence of infection in primary care: a matched cohort study. BMC Infect Dis. 2018;18(1):67. https://doi.org/10.1186/s12879‐018‐2975‐2
Gulliford M, Latinovic R, Charlton J, Little P, van Staa T, Ashworth M. Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006. J Publ Health. 2009;31(4):512‐520. https://doi.org/10.1093/pubmed/fdp081
Ciftci Z, Develioglu O, Arbak S, Ozdoganoglu T, Gultekin E. A new horizon in the treatment of biofilm‐associated tonsillitis. Ther Adv Respir Dis. 2014;8(3):78‐83. https://doi.org/10.1177/1753465814529177
Davcheva‐Chakar M, Kaftandzhieva A, Zafirovska B. Adenoid vegetations – reservoir of bacteria for chronic otitis media with effusion and chronic rhinosinusitis. Prilozi. 2015;36(3):71‐76. https://doi.org/10.1515/prilozi‐2015‐0080
Kim SK, Park MW, Min C, et al. Increased risk of chronic otitis media in chronic rhinosinusitis patients: a longitudinal follow‐up study using a national health screening cohort. Rhinology. 2021;59(3):292‐300. https://doi.org/10.4193/Rhin20.363
Arndal E, Sørensen AL, Lapperre TS, et al. Chronic rhinosinusitis in COPD: a prevalent but unrecognized comorbidity impacting health related quality of life. Respir Med. 2020;171:106092. https://doi.org/10.1016/j.rmed.2020.106092
Stevens WW, Peters AT, Hirsch AG, et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin‐exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2017;5(4):1061.e3‐1070.e3. https://doi.org/10.1016/j.jaip.2016.12.027
Toppila‐Salmi S, Rihkanen H, Arffman M, Manderbacka K, Keskimaki I, Hytönen ML. Regional differences in endoscopic sinus surgery in Finland: a nationwide register‐based study. BMJ Open. 2018;8(10):e022173. https://doi.org/10.1136/bmjopen‐2018‐022173
Toppila‐Salmi S, Hällfors J, Aakko J, et al. The burden of chronic rhinosinusitis with nasal polyps and its relation to asthma in Finland. Clin Transl Allergy. 2022;12(10):e12200. https://doi.org/10.1002/clt2.12200
Ramadan HH, Bulbul MG, Asad F, Wasef K, Makary CA. Complications of primary pediatric endoscopic sinus surgery for chronic rhinosinusitis: a 25‐year single surgeon experience. Laryngoscope Investig Otolaryngol. 2022;7(3):658‐661. https://doi.org/10.1002/lio2.791
Stankiewicz JA, Lal D, Connor M, Welch K. Complications in endoscopic sinus surgery for chronic rhinosinusitis: a 25‐year experience. Laryngoscope. 2011;121(12):2684‐2701. https://doi.org/10.1002/lary.21446
Ramadan HH. Relation of age to outcome after endoscopic sinus surgery in children. Arch Otolaryngol Head Neck Surg. 2003;129(2):175‐177. https://doi.org/10.1001/archotol.129.2.175
Ramadan HH, Tiu J. Failures of adenoidectomy for chronic rhinosinusitis in children: for whom and when do they fail? Laryngoscope. 2007;117(6):1080‐1083. https://doi.org/10.1097/MLG.0b013e31804154b1
Mazza JM, Lin SY. Primary immunodeficiency and recalcitrant chronic sinusitis: a systematic review: immunodeficiency and sinusitis. Int Forum Allergy Rhinol. 2016;6(10):1029‐1033. https://doi.org/10.1002/alr.21789
Masterson L, Tanweer F, Bueser T, Leong P. Extensive endoscopic sinus surgery: does this reduce the revision rate for nasal polyposis? Eur Arch Oto‐Rhino‐Laryngol. 2010;267(10):1557‐1561. https://doi.org/10.1007/s00405‐010‐1233‐z
Suzuki S, Yasunaga H, Matsui H, Fushimi K, Kondo K, Yamasoba T. Complication rates after functional endoscopic sinus surgery: analysis of 50,734 Japanese patients. Laryngoscope. 2015;125(8):1785‐1791. https://doi.org/10.1002/lary.25334
Oomen KPQ, April MM. Sinonasal manifestations in cystic fibrosis. Int J Otolaryngol. 2012;2012:789572‐789577. https://doi.org/10.1155/2012/789572
Hosie PH, Fitzgerald DA, Jaffe A, Birman CS, Rutland J, Morgan LC. Presentation of primary ciliary dyskinesia in children: 30 years’ experience. J Paediatr Child Health. 2015;51(7):722‐726. https://doi.org/10.1111/jpc.12791
Kere J, Norio R, Savilahti E, Estivill X, de la Chapelle A. Cystic fibrosis in Finland: a molecular and genealogical study. Hum Genet. 1989;83(1):20‐25. https://doi.org/10.1007/BF00274141
Wuokko‐Landén A, Blomgren K, Suomalainen A, Välimaa H. Odontogenic causes complicating the chronic rhinosinusitis diagnosis. Clin Oral Invest. 2021;25(3):947‐955. https://doi.org/10.1007/s00784‐020‐03384‐4

Auteurs

Aada Murtomäki (A)

Inflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Department of Otorhinolaryngology, University of Eastern Finland, Jouensuu, Kuopio, Finland.

Alma Helevä (A)

Inflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Programme of the Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Paulus Torkki (P)

Department of Public Health, University of Helsinki, Helsinki, Finland.

Jari Haukka (J)

Department of Public Health, University of Helsinki, Helsinki, Finland.

Anna Julkunen-Iivari (A)

Inflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Riikka Lemmetyinen (R)

Inflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Department of Public Health, University of Helsinki, Helsinki, Finland.

Mika Mäkelä (M)

Inflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Aarno Dietz (A)

Department of Otorhinolaryngology, University of Eastern Finland, Jouensuu, Kuopio, Finland.
Department of Otorhinolaryngology, Kuopio University Hospital, Wellbeing Services County of North Savo, Kuopio, Finland.

Mikko Nuutinen (M)

Inflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Sanna Toppila-Salmi (S)

Inflammation Center, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Department of Otorhinolaryngology, University of Eastern Finland, Jouensuu, Kuopio, Finland.
Department of Otorhinolaryngology, Kuopio University Hospital, Wellbeing Services County of North Savo, Kuopio, Finland.

Classifications MeSH